Reut Puni
Overview
Explore the profile of Reut Puni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
199
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boby M, Fearon D, Ferla M, Filep M, Koekemoer L, Robinson M, et al.
Science
. 2023 Nov;
382(6671):eabo7201.
PMID: 37943932
We report the results of the COVID Moonshot, a fully open-science, crowdsourced, and structure-enabled drug discovery campaign targeting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease. We discovered...
2.
Glinert I, Bar-David E, Ben-Shmuel A, Sittner A, Puni R, Laredo S, et al.
PLoS One
. 2023 Feb;
18(2):e0281879.
PMID: 36795682
Bacillus anthracis overcomes host immune responses by producing capsule and secreting toxins. Production of these virulence factors in response to entering the host environment was shown to be regulated by...
3.
Fisher M, Levy H, Fatelevich E, Afrimov Y, Ben-Shmuel A, Rosenfeld R, et al.
Microbiol Spectr
. 2021 Oct;
9(2):e0087021.
PMID: 34612689
The first case of SARS-CoV-2 was discovered in Israel in late February 2020. Three major outbreaks followed, resulting in over 800,000 cases and over 6,000 deaths by April 2021. Our...
4.
Barlev-Gross M, Weiss S, Ben-Shmuel A, Sittner A, Eden K, Mazuz N, et al.
Anal Bioanal Chem
. 2021 Mar;
413(13):3501-3510.
PMID: 33768365
Public health experts emphasize the need for quick, point-of-care SARS-CoV-2 detection as an effective strategy for controlling virus spread. To this end, many "antigen" detection devices were developed and commercialized....
5.
Yahalom-Ronen Y, Tamir H, Melamed S, Politi B, Shifman O, Achdout H, et al.
Nat Commun
. 2020 Dec;
11(1):6402.
PMID: 33328475
The COVID-19 pandemic caused by SARS-CoV-2 imposes an urgent need for rapid development of an efficient and cost-effective vaccine, suitable for mass immunization. Here, we show the development of a...